IRVINE, Calif.--(BUSINESS WIRE)--Endologix, Inc. (Nasdaq:ELGX) today announced the first seven Powerlink® System procedures for the minimally invasive treatment of abdominal aortic aneurysms (AAA) have been successfully performed using the Company’s advanced Visiflex Integrated System, or Visiflex IS.
